Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Managing a grossly comminuted and infected mandibular fracture using a maxillary extra-oral distractor as stabilizing agent: A clinical case report.

Chao DM, Jin S, Khatri KS, Long ZJ, Lei T, Lisheng H.

Trauma Case Rep. 2017 Mar 18;9:10-12. doi: 10.1016/j.tcr.2017.01.014. eCollection 2017 Jun.

2.

Development of polyol-responsive antibody mimetics for single-step protein purification.

Suderman RJ, Rice DA, Gibson SD, Strick EJ, Chao DM.

Protein Expr Purif. 2017 Jun;134:114-124. doi: 10.1016/j.pep.2017.04.008. Epub 2017 Apr 17.

3.

A facile strategy to decorate Cu₉S₅ nanocrystals on polyaniline nanowires and their synergetic catalytic properties.

Lu XF, Bian XJ, Li ZC, Chao DM, Wang C.

Sci Rep. 2013 Oct 16;3:2955. doi: 10.1038/srep02955.

4.

Inhibition of nociceptin/orphanin FQ on penicillin-induced seizures in rats.

Feng Y, Chao DM, Li WM, Cao YX, Wang YQ, Wu GC.

Brain Res. 2004 Sep 10;1020(1-2):214-9.

PMID:
15312806
5.

[Role of melatonin in spatial learning and memory in rats and its mechanism].

Feng Y, Zhang LX, Chao DM.

Sheng Li Xue Bao. 2002 Feb 25;54(1):65-70. Chinese.

6.
7.

Melatonin might be one possible medium of electroacupuncture anti-seizures.

Chao DM, Chen G, Cheng JS.

Acupunct Electrother Res. 2001;26(1-2):39-48.

PMID:
11394492
8.

Naloxone reverses inhibitory effect of electroacupuncture on sympathetic cardiovascular reflex responses.

Chao DM, Shen LL, Tjen-A-Looi S, Pitsillides KF, Li P, Longhurst JC.

Am J Physiol. 1999 Jun;276(6):H2127-34. doi: 10.1152/ajpheart.1999.276.6.H2127.

PMID:
10362696
9.

A strategy for rapid, high-confidence protein identification.

Qin J, Fenyö D, Zhao Y, Hall WW, Chao DM, Wilson CJ, Young RA, Chait BT.

Anal Chem. 1997 Oct 1;69(19):3995-4001.

PMID:
9322436
10.

BRCA1 is a component of the RNA polymerase II holoenzyme.

Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5605-10.

11.

Functional antagonism between RNA polymerase II holoenzyme and global negative regulator NC2 in vivo.

Gadbois EL, Chao DM, Reese JC, Green MR, Young RA.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3145-50.

12.

Activation without a vital ingredient.

Chao DM, Young RA.

Nature. 1996 Sep 12;383(6596):119-20. No abstract available.

PMID:
8774874
13.

A mammalian SRB protein associated with an RNA polymerase II holoenzyme.

Chao DM, Gadbois EL, Murray PJ, Anderson SF, Sonu MS, Parvin JD, Young RA.

Nature. 1996 Mar 7;380(6569):82-5.

PMID:
8598913
14.

RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling.

Wilson CJ, Chao DM, Imbalzano AN, Schnitzler GR, Kingston RE, Young RA.

Cell. 1996 Jan 26;84(2):235-44.

15.

Purification of yeast RNA polymerase II holoenzymes.

Koleske AJ, Chao DM, Young RA.

Methods Enzymol. 1996;273:176-84. Review. No abstract available.

PMID:
8791611
16.

Association of an activator with an RNA polymerase II holoenzyme.

Hengartner CJ, Thompson CM, Zhang J, Chao DM, Liao SM, Koleske AJ, Okamura S, Young RA.

Genes Dev. 1995 Apr 15;9(8):897-910.

17.

A kinase-cyclin pair in the RNA polymerase II holoenzyme.

Liao SM, Zhang J, Jeffery DA, Koleske AJ, Thompson CM, Chao DM, Viljoen M, van Vuuren HJ, Young RA.

Nature. 1995 Mar 9;374(6518):193-6.

PMID:
7877695
18.

A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast.

Thompson CM, Koleske AJ, Chao DM, Young RA.

Cell. 1993 Jul 2;73(7):1361-75.

PMID:
8324825
19.

Tailored tails and transcription initiation: the carboxyl terminal domain of RNA polymerase II.

Chao DM, Young RA.

Gene Expr. 1991 Apr;1(1):1-4. Review. No abstract available.

Supplemental Content

Support Center